Register Login

All Posts

Heparin Resistance in Pancreatitis

Click this open-access article to read about heparin resistance in an acute pancreatitis patient with a normal antithrombin level: Rongqin D, Zhexin B, Yuzhi L, et al. Heparin resistance in a patient with severe acute pancreatitis: a case report. Lab Med. 2025;56:570–6. doi: 10.1093/labmed/lmae126. PMID: 40237706; PMCID: PMC12417076. Here’s the abstract: Introduction: Severe acute pancreatitis […]
read more

Cell-based Coagulation Overview

Check your medical library to read Harris NS, Marin MJ, Butenas S. Beyond prothrombin time and activated partial thromboplastin time: coagulation in vivo-an illustrated review. Lab Med. 2025;56:438–47. doi: 10.1093/labmed/lmae125. PMID: 40319459. Here’s the abstract: The steps that initiate coagulation in vivo are different from the components of prothrombin time (PT) and activated partial thromboplastin time […]
read more

APL Positivity Cutoffs: 99th Percentile?

For a fresh look at anticardiolipin antibody and anti-β2-GP1 analysis decision points, click Anunciación-Llunell A, Marques-Soares J, Ockova M, et al. The absence of standardization in antiphospholipid antibody testing may favor the use of 99th percentile cutoffs in antiphospholipid syndrome classification. Res Pract Thromb Haemost. 2025;9:102967. doi: 10.1016/j.rpth.2025.102967. PMID: 40761700; PMCID: PMC12320162.
read more

Poster: Monitoring FVIII in Hemophilia Patients Treated with Bypassing Therapeutics

To review the PBI poster presented at the 2025 ISTH meeting, click Effect of Mim8 and Emicizumab on Factor VIII Recovery by a Novel, Bovine Chromogenic FVIII Assay. Tara Quinton, Meghan Bruhm, Karen M. Black, Ali Sadeghi-Khomami. Precision BioLogic Inc., Dartmouth, Nova Scotia, Canada. The poster illustrates the validity of bovine reagent-based chromogenic substrate FVIII […]
read more